Separately, Piper Jaffray Companies assumed coverage on shares of Motus GI in a report on Sunday. They issued an overweight rating and a $7.00 price objective for the company.
Shares of Motus GI (MOTS) opened at $4.81 on Monday. Motus GI has a 1-year low of $3.75 and a 1-year high of $5.30.
ILLEGAL ACTIVITY WARNING: This news story was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this news story on another publication, it was copied illegally and reposted in violation of international trademark and copyright laws. The legal version of this news story can be read at https://sportsperspectives.com/2018/03/13/motus-gi-mots-receives-new-coverage-from-analysts-at-oppenheimer.html.
Motus GI Company Profile
Motus GI Holdings, Inc is a medical technology company. The Company is developing Pure-Vu system that integrates with existing colonoscopes to cleanse poorly prepped colons during the colonoscopy procedure. The Pure-Vu system uses a precise mixture of water and air to loosen debris from the colon mucosa while simultaneously evacuating the bowel contents, clearing the way for the endoscopist to perform a high quality examination, even when the patient is not fully clean prior to their procedure.
Receive News & Ratings for Motus GI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Motus GI and related companies with MarketBeat.com's FREE daily email newsletter.